Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 48Terminated 12Unknown 4Withdrawn 2Active not recruiting 2Suspended 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma 2Leukemia, Myeloid, Acute 2Hematologic Neoplasms 2Breast Neoplasms 2Stomach Neoplasms 1Rectal Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Osteosarcoma 1Neuroblastoma 1Neoplasms 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1HTLV-I Infections 1Esophageal Neoplasms 1Enteropathy-Associated T-Cell Lymphoma 1Congenital Abnormalities 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

zanubrutinib 1Vincristine 1Rituximab 1Prednisone 1Epirubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Congenital Abnormalities × Cyclophosphamide × Clear all
NCT04668365 2025-04-25

Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma

Henan Cancer Hospital

Phase 2 Suspended
59 enrolled
Lymphoid

Congenital Abnormalities, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡